Noticias de MYGN_US

Noticias del mercado

Últimas noticias sobre MYGN_US — 241 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: MYGN_US ✕ 241 resultados
06/04/2026 MYGN_US — tayninh.gov.vn
Can Myriad Genetics (MYGN) Stock Beat Estimates | Price at $4.76, Up 0.21% - Late Breakout
06/04/2026 MYGN_US — GlobeNewswire
Myriad Genetics, Inc. Investigated by the Portnoy Law Firm
06/04/2026 MYGN_US — Yahoo Finance
Myriad Genetics And 2 Other Penny Stocks To Watch Closely
31/03/2026 MYGN_US — Seeking Alpha
Myriad Genetics: SOTP Suggests The Company Is Undervalued
27/03/2026 MYGN_US — Stock Titan
Vanguard (MYGN) amendment shows 0 shares; subsidiaries disaggregate holdings
25/03/2026 MYGN_US — The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga
25/03/2026 MYGN_US — Yahoo Finance
Myriad (MYGN) Up 4.1% Since Last Earnings Report: Can It Continue?
23/03/2026 MYGN_US — Stock Titan
Myriad Genetics (MYGN) CSO has shares withheld to cover RSU taxes
23/03/2026 MYGN_US — Stock Titan
Myriad Genetics (MYGN) COO has 2,055 shares withheld to cover taxes
23/03/2026 MYGN_US — Stock Titan
Myriad Genetics (MYGN) CFO uses 549 shares for RSU tax withholding
22/03/2026 MYGN_US — MarketScreener
Myriad Genetics, Inc.(NasdaqGS: MYGN) dropped from S&P 600 Health Care
19/03/2026 MYGN_US — Yahoo Finance
Why Myriad Genetics (MYGN) is a Top Growth Stock for the Long-Term
17/03/2026 MYGN_US — Yahoo Finance
Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer
17/03/2026 MYGN_US — GlobeNewswire ES ← EN
Myriad Genetics recibe la aprobación de la FDA para MyChoice CDx
17/03/2026 MYGN_US — Stock Titan
FDA approves genetic test to match ovarian cancer patients to Zejula
17/03/2026 MYGN_US — Investing.com
Myriad Genetics receives FDA approval for ovarian cancer test
17/03/2026 MYGN_US — GlobeNewswire
Myriad Genetics Receives FDA Approval of the MyChoice CDx
16/03/2026 MYGN_US — Stock Titan
Myriad Genetics (MYGN) CSO gets 173,196 RSUs, withholds 37,799 shares
16/03/2026 MYGN_US — Stock Titan
Myriad Genetics (MYGN) CTO has shares withheld to cover taxes
16/03/2026 MYGN_US — Stock Titan
Myriad Genetics (MYGN) Chief Commercial Officer granted 226,804 RSUs

Página 12 de 13

keyboard_arrow_up